Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 15, 2022
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
Fri, August 12, 2022
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
Daniil Gataulin Maintained (ADVM) at Hold with Decreased Target to $25 on, Aug 12th, 2022
Daniil Gataulin of Chardan Capital, Maintained "Adverum Biotechnologies, Inc." (ADVM) at Hold with Decreased Target from $30 to $25 on, Aug 12th, 2022.
Daniil has made no other calls on ADVM in the last 4 months.
There is 1 other peer that has a rating on ADVM. Out of the 1 peers that are also analyzing ADVM, 0 agree with Daniil's Rating of Hold.
This is the rating of the analyst that currently disagrees with Daniil
- Joon Lee of "Truist Securities" Upgraded from Hold to Strong Buy and Increased Target to $40 on, Thursday, July 7th, 2022
